Manchester Capital Management LLC Gilead Sciences, Inc. Transaction History

Manchester Capital Management LLC

$829 Million
Q3 2024

A detailed history of Manchester Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 22,578 shares of GILD stock, worth $2.12 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

22,578

Previous 22,095 2.19%

Holding current value

$2.12 Million

Previous $1.52 Million 24.88%

% of portfolio

0.23%

Previous 0.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$66.59 - $83.99 $32,162 - $40,567	483 Added 2.19%	22,578 $1.89 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $49,130 - $56,700	778 Added 3.65%	22,095 $1.52 Million
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $37,579 - $45,827	-525 Reduced 2.4%	21,317 $1.56 Million
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $13,554 - $15,371	185 Added 0.85%	21,842 $1.77 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $34,603 - $37,753	468 Added 2.21%	21,657 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $10,261 - $11,704	135 Added 0.64%	21,189 $1.63 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $15,462 - $17,616	-200 Reduced 0.94%	21,054 $1.75 Million
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $1,682 - $2,415	27 Added 0.13%	21,254 $1.82 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $59,540 - $68,010	-1,000 Reduced 4.5%	21,227 $1.31 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $48,900 - $55,794	-815 Reduced 3.54%	22,227 $1.44 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $21,810 - $24,851	-385 Reduced 1.64%	23,042 $1.34 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $9,315 - $11,712	-150 Reduced 0.64%	23,427 $1.48 Million
Q2 2020 Sep 28, 2020	SELL	$72.34 - $84.0 $7,234 - $8,400	-100 Reduced 0.42%	23,577 $1.81 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $939 - $1,203	15 Added 0.06%	23,677 $1.77 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $118,310 - $130,137	1,920 Added 8.83%	23,662 $1.54 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $19,489 - $21,854	-315 Reduced 1.43%	21,742 $1.47 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $142,255 - $159,363	2,275 Added 11.5%	22,057 $1.43 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $489,260 - $570,702	7,541 Added 61.6%	19,782 $1.4 Million
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $352,618 - $429,880	-4,841 Reduced 28.34%	12,241 $923,000
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $711,500 - $835,200	10,000 Added 141.2%	17,082 $1.22 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $510,683 - $605,298	7,082	7,082 $574,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Gilead Sciences, Inc. Transaction History